Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals

NCT03884062 · clinicaltrials.gov ↗

COMPLETED

Status

3000

Enrollment

OTHER

Sponsor class

Conditions

HCC in Chronic HCV Patients With Advanced Liver Fibrosis

Interventions

DRUG: DAAs

Sponsor

Egyptian Liver Hospital